Glazer Capital LLC’s Longevity Acquisition Corporation Ordinary Shares LOAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-203,841
Closed -$2.43M 852
2020
Q4
$2.43M Sell
203,841
-125,260
-38% -$1.38M 0.09% 203
2020
Q3
$3.49M Sell
329,101
-963
-0.3% -$10.3K 0.17% 135
2020
Q2
$3.52M Buy
330,064
+73,320
+29% +$776K 0.25% 81
2020
Q1
$2.68M Buy
256,744
+128,150
+100% +$1.34M 0.18% 88
2019
Q4
$1.34M Sell
128,594
-20,303
-14% -$211K 0.17% 80
2019
Q3
$1.53M Sell
148,897
-32,510
-18% -$332K 0.19% 77
2019
Q2
$1.83M Sell
181,407
-12,000
-6% -$121K 0.21% 74
2019
Q1
$1.93M Buy
193,407
+10,012
+5% +$99.8K 0.28% 65
2018
Q4
$1.84M Buy
+183,395
New +$1.8M 0.25% 70

Glazer Capital LLC's LOAC Position: Q1 2021 in Review

Glazer Capital LLC sold out of Longevity Acquisition Corporation Ordinary Shares (LOAC) in Q1 2021, closing a stake of 203,841 shares — an estimated $2.43M sold.

Glazer Capital LLC first reported a position in LOAC in Q4 2018 and held it in 9 quarters. The position peaked at $3.52M in Q2 2020. 0 funds tracked by Wall St. Rank hold LOAC as of Q1 2021.

  • Glazer Capital LLC reported no remaining Longevity Acquisition Corporation Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Glazer Capital LLC sold 203,841 Longevity Acquisition Corporation Ordinary Shares shares in Q1 2021, an estimated $2.43M.
  • Glazer Capital LLC first reported a position in Longevity Acquisition Corporation Ordinary Shares in Q4 2018 and held it in 9 quarters.
  • Glazer Capital LLC's Longevity Acquisition Corporation Ordinary Shares position peaked at $3.52M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Longevity Acquisition Corporation Ordinary Shares as of Q1 2021.

Based on Glazer Capital LLC's 13F filing for Q1 2021, filed 14 May 2021.